Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaginal microbiota composition refers to the distribution and balance of microbial inhabitants within the vagina, primarily bacterial species, which form discrete community state types (CSTs) dominated either by specific Lactobacillus species or by diverse anaerobic bacteria. This ecosystem is dynamic, influenced by hormonal changes, age, sexual activity, and interventions, and its balance is crucial for genital tract health. Imbalances (dysbiosis) are linked to increased risk of infection, adverse reproductive outcomes, and broader health implications. Unlike individual molecular targets, vaginal microbiota composition is an ecological index rather than a conventional drug target or receptor.
Antibiotics reduce overgrowth of pathogenic anaerobes Antifungals eliminate pathogenic yeasts Probiotics restore dominance of protective Lactobacillus spp., promote low vaginal pH, and outcompete pathogens
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal microbiota composition.